TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple SclerosisNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATIONIF7.52023-09-017OAAI
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PETBRAIN COMMUNICATIONSIF4.52021-12-2219OAAI
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosisBRAINIF11.72020-10-0290OAAI
未登录.png){kind=icon}
未登录
